Report
Janaghan Jeyakumar
EUR 4.56 For Business Accounts Only

JKSB Quarterly Highlights_Seylan Bank PLC (SEYB)_3QCY16

Note:

Healthy growth in total operating income (driven by both NII & non-interest income)

SEYB's net interest income experienced a healthy increase of 12.9% YoY as the positive impact from the strong loan book growth of 29.1% YoY was partially offset by the YoY contraction of NIMs from 4.54% to 4.00%. On the other hand, SEYB's non-interest income increased sharply by 46.3% YoY mainly with the help of the steep rise in net trading income (+Rs.402 Mn) which was driven by the mark-to-market profits stemming from favourable rate movements during the quarter. Consequently, the proportion of non-interest income in total operating income (before impairment) increased from 22.6% to 27.5%.

Higher impairment charges and operating expenses affected bottom line growth

SEYB's total impairment charges for the quarter were higher by Rs.324 Mn comparing to 3Q CY15 which included a reversal of Rs.222 Mn in collective impairment charges. Although SEYB's total operating income increased by 20.4% YoY, the increase in impairment charges restricted the growth in net operating income to 12.0% YoY. In addition to this, SEYB's bottom line growth was affected by the 15.1% YoY increase in operating expenses. Consequently, SEYB recorded an 8.1% YoY increase in earnings to equity during the quarter. For the cumulative period 9M CY16, SEYB's earnings have increased marginally by 3.7% YoY.

We project SEYB's full-year earnings to reach Rs.4 bn in CY16E

We project SEYB's full year earnings for CY16E to reach Rs.4.0 bn, which would translate to PE Ratios of 7.7x and 5.3x for the voting and non-voting shares at the current trading price of Rs.90.00 and Rs.61.50 respectively. Furthermore, the DPS declared of Rs.2.75 declared by SEYB in CY16 translates to dividend yields of 3.1% and 4.5% for the voting and non-voting shares respectively.

Underlying
Seylan Bank

Provider
John Keells Stock Brokers
John Keells Stock Brokers

​•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.

•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s

•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.

•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley

•JKSB is a research contributor to Bloomberg on ‘KEEL’ , Thomson First Call, Reuters Knowledge and FactSet

•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.

•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.

Analysts
Janaghan Jeyakumar

Other Reports on these Companies
Other Reports from John Keells Stock Brokers

ResearchPool Subscriptions

Get the most out of your insights

Get in touch